Fortis shares fall 20% as Malaysian company’s open offer remains on hold


IHH Healthcare had won a bid for a 31% stake in Fortis in 2018.


Shares of Fortis Healthcare fell nearly 20% on Thursday, seeing their biggest drop in nearly 15 years, after reports said the highest court ordered the continuation of a stay on IHH Healthcare’s open offer for the company.

The Supreme Court also referred the issue of the Fortis-IHH deal to the Delhi High Court and ordered it to consider appointing a forensic auditor, UKTN TV-18 reported.

See also  Canela.TV, a free Spanish-language streaming service with 23 million users, launches original shows

Reuters was unable to immediately assess the order.

IHH had won an offer for a 31% stake in Fortis in 2018, leading to an open offer for a further 26% under Indian regulations.

The Supreme Court had blocked the open offer based on a plea filed by Japanese drugmaker Daiichi Sankyo, which sought to enforce an arbitration decision it won in a Singaporean court for a fraud claim against Fortis founders Malvinder Singh and Shivinder Singh.

See also  Twitter whistleblower to detail 'serious' security threats ahead of Elon Musk Deal vote

“…Supreme Court proceedings have been closed with certain directions and the suo-motu contempt is over. We are seeking legal advice to determine our future course of action,” Fortis said in a statement to the exchanges on Thursday.

Fortis shares fell the most since January 2008, with trading volumes around 21 times the 30-day average as of 0807 GMT

IHH and Daiichi did not immediately respond to Reuters’ requests for comment.

See also  Ads for Gordon Ramsay's gin banned over honeyberry claims



Please enter your comment!
Please enter your name here